“…As in A, before n-SMase action SM stabilizes membrane structure, while Cer production by n-SMase induces spontaneous negative curvature to the membrane of endosomes, thus promoting the formation of internal vesicles inside MVBs. Subsequent in vitro works reported that, while exogenous cell permeable C6 Cer dose-dependently increases the number of exosomes released from multiple myeloma cells (51), pharmacological or genetic block of n-SMase inhibited packaging of the prion protein into exosomes (52) and reduced exosome release among others in HEK cells (53), T cells (54), N2a cells (55), astrocytes (56), microglia (57), macrophages (58), hepatocytes (59), and multiple myeloma cells (51). Also, in vivo, in the brain and serum of 5XFAD mice, a transgenic model of Alzheimer's disease (AD), the n-SMase inhibitor, GW4869, decreased exosome concentration (60).…”